Sortino ratio is not yet available for HOLX. This metric requires at least 12 months of historical daily returns to calculate. Check back once this data is available.
How it compares to other similar stocks
The table compares Hologic, Inc.'s Sortino Ratio with other stocks in the Medical Instruments & Supplies industry across multiple time periods, showing how HOLX's risk-adjusted performance compares to industry peers.
Data shows 1-, 5-, and 10-year periods, plus each stock's all-time average, as of Jun 4, 2026.
| Symbol | Name | 1Y Sortino Ratio | 5Y Sortino Ratio | 10Y Sortino Ratio | All Time Sortino Ratio |
|---|---|---|---|---|---|
| NNNN | Anbio Biotechnology Class A | 2.67 | |||
| WST | West Pharmaceutical Services, Inc. | 2.29 | |||
| STAA | STAAR Surgical Company | 2.14 | |||
| AVR | Anteris Technologies Global Corp | 2.14 | |||
| HOCPY | Hoya Corp | 2.02 | |||
| VXIT | VirExit Technologies, Inc. | 1.68 | |||
| INFU | InfuSystem Holdings Inc. | 1.67 | |||
| HBIO | Harvard Bioscience, Inc. | 1.63 | |||
| PLSE | Pulse Biosciences, Inc. | 1.57 | |||
| LUCYW | Innovative Eyewear Inc | 1.49 | |||
| HOLX | Hologic, Inc. | — |
Historical Sortino Ratio
The chart shows HOLX's rolling Sortino ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to downside risk, while declining trends may signal deteriorating risk-adjusted performance or increased volatility during market stress. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.
Identify market cycles by observing when HOLX consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.
Loading charts...
IHow does HOLX fit in your portfolio?
Add your other holdings to see your portfolio's Sortino Ratio and find out.
Analyze Your Portfolio